2 Value ETFs Offering Long-Term Opportunities As Markets Slide
Investing.com | May 10, 2022 04:06
Bear markets often create opportunities for seasoned investors as declines in share prices lead to new value investment options. So far this year, the S&P 500 and the NASDAQ 100 have lost 14.5% and 23.4%. Put another way, broader markets are beginning to offer suitable entry points.
Finding quality shares trading below their intrinsic value can become a critical and lucrative long-term strategy for seasoned investors. The intrinsic value refers to a stock’s actual value, or in other words, the measure of what a stock (or any asset for that matter) is really worth.
According to Warren Buffet, :
“…offers the only logical approach to evaluating the relative attractiveness of investments and businesses.”
Quantitative metrics usually help determine whether a stock offers value. Examples of ratios most commonly used include price-to-earnings (P/E), price-to-book value (P/B), price-to-sales (P/S), price-per-earnings-to-growth (PEG), debt-to-equity (D/E) or free cash flow (FCF).
What those metrics mean, or how to interpret them, requires more research and typically depends on the industry. The website can rank values for stocks, their peers, and the industry. So, a P/E of around 20x for a tech stock might mean it potentially offers value.
However, the same argument does not necessarily apply to shares of utilities, where we see lower ratios. The NYU Stern School of Business an updated list of P/E ratios for different sectors in the US.
Today’s post focuses on value stocks and presents two exchange-traded funds (ETFs) that invest in them:
h2 1. Vanguard S&P Mid-Cap 400 Value Index Fund ETF Shares/h2- Current Price: $152.32
- 52-week range: $151.77 - $176.31
- Dividend Yield: 1.94%
- Expense ratio: 0.15% per year
Get The App
Our first fund, the Vanguard S&P Mid-Cap 400 Value Index Fund ETF Shares (NYSE:IVOV), offers exposure to mid-cap US value companies from the underlying S&P Midcap 400 Index. The names are selected based on three factors, including earnings/price, book/price, and sales/price ratios.
This passively managed fund was first launched in September 2010. It currently holds a portfolio of 295 stocks, where the top 10 names comprise roughly 9% of $943 million in net assets.
Industrials have the largest slice with 19.40% in sectoral allocations. Next come financials (17%), consumer discretionary (12.70%), real estate (11.30%), and information technology (10.40%).
Leading holdings include Medical Properties (NYSE:MPW), a real estate investment trust (REIT) specializing in healthcare facilities; financial services stock First Horizon National (NYSE:FHN); property and casualty insurance name Alleghany (NYSE:Y); metal service group Reliance Steel & Aluminum Co. (NYSE:RS); and Aecom Technology (NYSE:ACM), which provides infrastructure consulting services.
IVOV came under pressure after hitting an all-time high in November 2021. The fund has lost around 9.6% since January and 9.7% over the past 12 months. Trailing P/E and P/B ratios are 14.0x and 1.9x.
Although the current environment means grey clouds over Wall Street, mid-cap value stocks have historically against a backdrop of high inflation and increasing interest rates. Thus, investors with a horizon of three to five years could consider researching IVOV further.
h2 2. JPMorgan U.S. Value Factor ETF /h2- Current Price: $34.44
- 52-week range: $34.41 - $39.27
- Dividend yield: 2.31%
- Expense ratio: 0.12% per year
Next up on our list is the JPMorgan U.S. Value Factor ETF (NYSE:JVAL), which provides diversified access to large-cap US value companies from the Russell 2000 Index. The fund holds 340 holdings selected by relative valuation metrics, including book yield, earnings yield, dividend yield, and cash flow yield.
JVAL started trading in November 2017. The top 10 names comprise close to 17% of $524.92 million in net assets. With regards to sectoral exposure, technology leads with 27.3%, followed by consumer discretionary (14.8%), healthcare (13.5%), industrials (12.6%), and financials (10.6%).
Among those are UnitedHealth Group (NYSE:UNH); Apple (NASDAQ:AAPL); Exxon Mobil (NYSE:XOM); Microsoft (NASDAQ:MSFT), and Johnson & Johnson (NYSE:JNJ).
We believe JVAL deserves to be on the radar screen of value investors. JVAL hit a 52-week low yesterday and is down to 10.3% since the start of 2022. Trailing P/E and P/B ratios stand at 13.10x and 2.35x.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.